← Back to Clinical Trials
Recruiting NCT07095166

Monitoring Eating Across Locations (MEAL) - Timing, Intake, and Mealtime Evaluation (TIME)

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

Condition Pediatric Obesity
Sponsor Penn State University
Study Type INTERVENTIONAL
Phase N/A
Enrollment 100
Sex ALL
Min Age 6 Years
Max Age 9 Years
Start Date 2025-11-15
Completion 2027-06-15
Interventions
Meal Location

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

Increased availability of high-energy dense foods has contributed to a pediatric obesity epidemic, with 23% of United States children currently presenting with the disease. How children eat contributes to both overconsumption and greater adiposity. However, it is unclear if laboratory measures of children's eating style generalize to the home environment, where children consume two thirds of their total energy. The study will 1) test if child eating styles observed in the lab generalize to more ecologically valid home environments and 2) identify aspects of home food environment that amplify obesogenic eating behaviors. We will assess laboratory and home eating styles (e.g., bite rate) in 100 prepubertal 6-9-year-old children to constrain variability in energy requirements. Children will be video-recorded while consuming identical study-provided meals at home and in the laboratory (counter-balanced order) in addition to a 'typical' meal at home. To study how adiposity relates to "obesogenic" styles of eating, gold standard dual x-ray absorptiometry will be used.

Eligibility Criteria

Inclusion Criteria: * children must be between the ages of 6-9 years-old * children are of good health with no learning disabilities (e.g., ADHD, determined by parent report) * children are not on any medications known to impact body weight, taste, food intake, behavior, or blood flow * parents report that children like and are willing to eat study foods Exclusion Criteria: * Children are not within the age requirements (\<6 years old or \> 9 years old) * If children are taking cold or allergy medication, or other medications known to influence cognitive function, taste, appetite, or blood flow. * If children don't speak English. * If children are colorblind. * If children have a learning disability, ADD/ADHD, language delays, autism or other neurological or psychological conditions. * If children have a pre-existing medical condition such as type I or type II diabetes, rheumatoid arthritis, Cushing's syndrome, Down's syndrome, severe lactose intolerance, Prader-Willi syndrome, HIV, ca

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology
}